Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of 5'Nucleotidase market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of 5'Nucleotidasemarket, defines the market attractiveness level of 5'Nucleotidase market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of 5'Nucleotidase industry, describes the types of 5'Nucleotidase market, the applications of major players and the market size, and deeply analyzes the current situation of the global 5'Nucleotidase market and the development prospects and opportunities of 5'Nucleotidase industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global 5'Nucleotidase market in Chapter 13.
By Player:
Corvus Pharmaceuticals Inc
Innate Pharma SA
Surface Oncology Inc
MedImmune LLC
Bristol-Myers Squibb Co
By Type:
CPX-006
IPH-53
AB-680
BMS-986179
Others
By End-User:
Colorectal Cancer
Fallopian Tube Cancer
Gastric Cancer
Metastatic Colorectal Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 5'Nucleotidase Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 5'Nucleotidase Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 5'Nucleotidase Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 5'Nucleotidase Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise 5'Nucleotidase Market Analysis and Outlook to 2022
-
7.1 Global 5'Nucleotidase Consumption (2017-2022)
-
7.2 United States 5'Nucleotidase Consumption (2017-2022)
-
7.3 Europe 5'Nucleotidase Consumption (2017-2022)
-
7.4 China 5'Nucleotidase Consumption (2017-2022)
-
7.5 Japan 5'Nucleotidase Consumption (2017-2022)
-
7.6 India 5'Nucleotidase Consumption (2017-2022)
-
7.7 South Korea 5'Nucleotidase Consumption (2017-2022)
8 Region and Country-wise 5'Nucleotidase Market Analysis and Outlook to 2028
-
8.1 Global 5'Nucleotidase Consumption Forecast (2022-2028)
-
8.2 United States 5'Nucleotidase Consumption Forecast (2022-2028)
-
8.3 Europe 5'Nucleotidase Consumption Forecast (2022-2028)
-
8.4 China 5'Nucleotidase Consumption Forecast (2022-2028)
-
8.5 Japan 5'Nucleotidase Consumption Forecast (2022-2028)
-
8.6 India 5'Nucleotidase Consumption Forecast (2022-2028)
-
8.7 South Korea 5'Nucleotidase Consumption Forecast (2022-2028)
9 Global 5'Nucleotidase Market Outlook by Types and Applications to 2022
-
9.1 Global 5'Nucleotidase Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CPX-006 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global IPH-53 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global AB-680 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global BMS-986179 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global 5'Nucleotidase Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Fallopian Tube Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastric Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global 5'Nucleotidase Market Outlook by Types and Applications to 2028
-
10.1 Global 5'Nucleotidase Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CPX-006 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global IPH-53 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global AB-680 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global BMS-986179 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global 5'Nucleotidase Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Fallopian Tube Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global 5'Nucleotidase Import and Export Analysis (Top 5 Countries)
-
11.1 Global 5'Nucleotidase Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global 5'Nucleotidase Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 5'Nucleotidase Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global 5'Nucleotidase Market Competitive Analysis
-
14.1 Corvus Pharmaceuticals Inc
-
14.1.1 Corvus Pharmaceuticals Inc Company Details
-
14.1.2 Corvus Pharmaceuticals Inc 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Corvus Pharmaceuticals Inc 5'Nucleotidase Product and Service
-
14.2 Innate Pharma SA
-
14.2.1 Innate Pharma SA Company Details
-
14.2.2 Innate Pharma SA 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Innate Pharma SA 5'Nucleotidase Product and Service
-
14.3 Surface Oncology Inc
-
14.3.1 Surface Oncology Inc Company Details
-
14.3.2 Surface Oncology Inc 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Surface Oncology Inc 5'Nucleotidase Product and Service
-
14.4 MedImmune LLC
-
14.4.1 MedImmune LLC Company Details
-
14.4.2 MedImmune LLC 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 MedImmune LLC 5'Nucleotidase Product and Service
-
14.5 Bristol-Myers Squibb Co
-
14.5.1 Bristol-Myers Squibb Co Company Details
-
14.5.2 Bristol-Myers Squibb Co 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Co 5'Nucleotidase Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of 5'Nucleotidase
-
Figure 5'Nucleotidase Picture
-
Table Global 5'Nucleotidase Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global 5'Nucleotidase Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global 5'Nucleotidase Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global 5'Nucleotidase Consumption by Country (2017-2022)
-
Figure United States 5'Nucleotidase Consumption and Growth Rate (2017-2022)
-
Table Europe 5'Nucleotidase Consumption and Growth Rate (2017-2022)
-
Figure China 5'Nucleotidase Consumption and Growth Rate (2017-2022)
-
Figure Japan 5'Nucleotidase Consumption and Growth Rate (2017-2022)
-
Figure India 5'Nucleotidase Consumption and Growth Rate (2017-2022)
-
Figure South Korea 5'Nucleotidase Consumption and Growth Rate (2017-2022)
-
Figure Global 5'Nucleotidase Consumption Forecast by Country (2022-2028)
-
Figure United States 5'Nucleotidase Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe 5'Nucleotidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure China 5'Nucleotidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan 5'Nucleotidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure India 5'Nucleotidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea 5'Nucleotidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CPX-006 Consumption and Growth Rate (2017-2022)
-
Figure Global IPH-53 Consumption and Growth Rate (2017-2022)
-
Figure Global AB-680 Consumption and Growth Rate (2017-2022)
-
Figure Global BMS-986179 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Fallopian Tube Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastric Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CPX-006 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IPH-53 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AB-680 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BMS-986179 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fallopian Tube Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global 5'Nucleotidase Import by Region (Top 5 Countries) (2017-2028)
-
Table Global 5'Nucleotidase Export by Region (Top 5 Countries) (2017-2028)
-
Table Corvus Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Corvus Pharmaceuticals Inc 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corvus Pharmaceuticals Inc 5'Nucleotidase Product and Service
-
Table Innate Pharma SA (Foundation Year, Company Profile and etc.)
-
Table Innate Pharma SA 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innate Pharma SA 5'Nucleotidase Product and Service
-
Table Surface Oncology Inc (Foundation Year, Company Profile and etc.)
-
Table Surface Oncology Inc 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Surface Oncology Inc 5'Nucleotidase Product and Service
-
Table MedImmune LLC (Foundation Year, Company Profile and etc.)
-
Table MedImmune LLC 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune LLC 5'Nucleotidase Product and Service
-
Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Co 5'Nucleotidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Co 5'Nucleotidase Product and Service
-
